Provider: Nature Publishing Group Content: application/x-research-info-systems TY - JOUR AU - Alter, H. J. AU - Seeff, L. B. TI - Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome JO - Semin. Liver Dis. PY - 2000/// VL - 20 SP - 17 EP - 35 M3 - 10.1055/s-2000-9505 N1 - 10.1055/s-2000-9505 UR - http://dx.doi.org/10.1055/s-2000-9505 ER - TY - JOUR AU - Lai, M. E. TI - Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children JO - Lancet PY - 1994/// VL - 343 SP - 388 EP - 390 M3 - 10.1016/S0140-6736(94)91224-6 N1 - 10.1016/S0140-6736(94)91224-6 UR - http://dx.doi.org/10.1016/S0140-6736(94)91224-6 ER - TY - JOUR AU - Simmonds, P. TI - Genetic diversity and evolution of hepatitis C virus [mdash] 15 years on JO - J. Gen. Virol. PY - 2004/// VL - 85 SP - 3173 EP - 3188 M3 - 10.1099/vir.0.80401-0 N1 - 10.1099/vir.0.80401-0 UR - http://dx.doi.org/10.1099/vir.0.80401-0 ER - TY - JOUR AU - Seeff, L. B. TI - Natural history of chronic hepatitis C JO - Hepatology PY - 2002/// VL - 36 SP - S35 EP - S46 M3 - 10.1053/jhep.2002.36806 N1 - 10.1053/jhep.2002.36806 UR - http://dx.doi.org/10.1053/jhep.2002.36806 ER - TY - JOUR AU - Mehta, S. H. TI - Protection against persistence of hepatitis C JO - Lancet PY - 2002/// VL - 359 SP - 1478 EP - 1483 M3 - 10.1016/S0140-6736(02)08435-0 N1 - 10.1016/S0140-6736(02)08435-0 UR - http://dx.doi.org/10.1016/S0140-6736(02)08435-0 ER - TY - JOUR AU - Weiner, A. J. TI - Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity JO - J. Virol. PY - 2001/// VL - 75 SP - 7142 EP - 7148 M3 - 10.1128/JVI.75.15.7142-7148.2001 N1 - 10.1128/JVI.75.15.7142-7148.2001 UR - http://dx.doi.org/10.1128/JVI.75.15.7142-7148.2001 ER - TY - JOUR AU - Bassett, S. E. TI - Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection JO - Hepatology PY - 2001/// VL - 33 SP - 1479 EP - 1487 M3 - 10.1053/jhep.2001.24371 N1 - 10.1053/jhep.2001.24371 UR - http://dx.doi.org/10.1053/jhep.2001.24371 ER - TY - JOUR AU - Lanford, R. E. TI - Cross-genotype immunity to hepatitis C virus JO - J. Virol. PY - 2004/// VL - 78 SP - 1575 EP - 1581 M3 - 10.1128/JVI.78.3.1575-1581.2004 N1 - 10.1128/JVI.78.3.1575-1581.2004 UR - http://dx.doi.org/10.1128/JVI.78.3.1575-1581.2004 ER - TY - JOUR AU - Farci, P. TI - Lack of protective immunity against reinfection with hepatitis C virus JO - Science PY - 1992/// VL - 258 SP - 135 EP - 140 ER - TY - JOUR AU - Wakita, T. TI - Production of infectious hepatitis C virus in tissue culture from a cloned viral genome JO - Nature Med. PY - 2005/// VL - 11 SP - 791 EP - 796 M3 - 10.1038/nm1268 N1 - 10.1038/nm1268 UR - http://dx.doi.org/10.1038/nm1268 ER - TY - JOUR AU - Zhong, J. TI - Robust hepatitis C virus infection in vitro JO - Proc. Natl Acad. Sci. USA PY - 2005/// VL - 102 SP - 9294 EP - 9299 M3 - 10.1073/pnas.0503596102 N1 - 10.1073/pnas.0503596102 UR - http://dx.doi.org/10.1073/pnas.0503596102 ER - TY - JOUR AU - Lindenbach, B. D. TI - Complete replication of hepatitis C virus in cell culture JO - Science PY - 2005/// VL - 309 SP - 623 EP - 626 M3 - 10.1126/science.1114016 N1 - 10.1126/science.1114016 UR - http://dx.doi.org/10.1126/science.1114016 ER - TY - JOUR AU - Polakos, N. K. TI - Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a non-classical ISCOM vaccine JO - J. Immunol. PY - 2001/// VL - 166 SP - 3589 EP - 3598 ER - TY - JOUR AU - Pearse, M. J. AU - Drane, D. TI - ISCOMATRIX adjuvant for antigen delivery JO - Adv. Drug Deliv. Rev. PY - 2005/// VL - 57 SP - 465 EP - 474 M3 - 10.1016/j.addr.2004.09.006 N1 - 10.1016/j.addr.2004.09.006 UR - http://dx.doi.org/10.1016/j.addr.2004.09.006 ER - TY - JOUR AU - Diepolder, H. M. TI - Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection JO - Lancet PY - 1995/// VL - 346 SP - 1006 EP - 1007 M3 - 10.1016/S0140-6736(95)91691-1 N1 - 10.1016/S0140-6736(95)91691-1 UR - http://dx.doi.org/10.1016/S0140-6736(95)91691-1 ER - TY - JOUR AU - Missale, G. TI - Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response JO - J. Clin. Invest. PY - 1996/// VL - 98 SP - 706 EP - 714 ER - TY - JOUR AU - Tsai, S. L. AU - Liaw, Y. F. AU - Chen, M. H. AU - Huang, C. Y. AU - Kuo, G. C. TI - Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity JO - Hepatology PY - 1997/// VL - 25 SP - 449 EP - 458 ER - TY - JOUR AU - Gerlach, J. T. TI - Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C JO - Gastroenterology PY - 1999/// VL - 117 SP - 933 EP - 941 ER - TY - JOUR AU - Cooper, S. TI - Analysis of a successful immune response against hepatitis C virus JO - Immunity PY - 1999/// VL - 10 SP - 439 EP - 449 M3 - 10.1016/S1074-7613(00)80044-8 N1 - 10.1016/S1074-7613(00)80044-8 UR - http://dx.doi.org/10.1016/S1074-7613(00)80044-8 ER - TY - JOUR AU - Thimme, R. AU - Oldach, D. AU - Chang, K. M. AU - Steiger, C. AU - Ray, S. C. AU - Chisari, F. V. TI - Determinants of viral clearance and persistence during acute hepatitis C virus infection JO - J. Exp. Med. PY - 2001/// VL - 194 SP - 1395 EP - 1406 M3 - 10.1084/jem.194.10.1395 N1 - 10.1084/jem.194.10.1395 UR - http://dx.doi.org/10.1084/jem.194.10.1395 ER - TY - JOUR AU - Grakoui, A. TI - HCV persistence and immune evasion in the absence of memory T cell help JO - Science PY - 2003/// VL - 302 SP - 659 EP - 662 M3 - 10.1126/science.1088774 N1 - 10.1126/science.1088774 UR - http://dx.doi.org/10.1126/science.1088774 ER - TY - JOUR AU - Shoukry, N. H. TI - Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection JO - J. Exp. Med. PY - 2003/// VL - 197 SP - 1645 EP - 1655 M3 - 10.1084/jem.20030239 N1 - 10.1084/jem.20030239 UR - http://dx.doi.org/10.1084/jem.20030239 ER - TY - JOUR AU - Lechner, F. TI - Analysis of successful immune responses in persons infected with hepatitis C virus JO - J. Exp. Med. PY - 2000/// VL - 191 SP - 1499 EP - 1512 M3 - 10.1084/jem.191.9.1499 N1 - 10.1084/jem.191.9.1499 UR - http://dx.doi.org/10.1084/jem.191.9.1499 ER - TY - JOUR AU - Lechner, F. TI - CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained JO - Eur. J. Immunol. PY - 2000/// VL - 30 SP - 2479 EP - 2487 M3 - 10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B N1 - 10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B UR - http://dx.doi.org/10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B ER - TY - JOUR AU - Frese, M. TI - Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs JO - Hepatology PY - 2002/// VL - 35 SP - 694 EP - 703 M3 - 10.1053/jhep.2002.31770 N1 - 10.1053/jhep.2002.31770 UR - http://dx.doi.org/10.1053/jhep.2002.31770 ER - TY - JOUR AU - Bartosch, B. TI - In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes JO - Proc. Natl Acad. Sci. USA PY - 2003/// VL - 100 SP - 14199 EP - 14204 M3 - 10.1073/pnas.2335981100 N1 - 10.1073/pnas.2335981100 UR - http://dx.doi.org/10.1073/pnas.2335981100 ER - TY - JOUR AU - Logvinoff, C. TI - Neutralizing antibody response during acute and chronic hepatitis C virus infection JO - Proc. Natl Acad. Sci. USA PY - 2004/// VL - 101 SP - 10149 EP - 10154 M3 - 10.1073/pnas.0403519101 N1 - 10.1073/pnas.0403519101 UR - http://dx.doi.org/10.1073/pnas.0403519101 ER - TY - JOUR AU - Meunier, J. C. TI - Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1 JO - Proc. Natl Acad. Sci. USA PY - 2005/// VL - 102 SP - 4560 EP - 4565 M3 - 10.1073/pnas.0501275102 N1 - 10.1073/pnas.0501275102 UR - http://dx.doi.org/10.1073/pnas.0501275102 ER - TY - JOUR AU - Lavillette, D. TI - Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection JO - J. Virol. PY - 2005/// VL - 79 SP - 6023 EP - 6034 M3 - 10.1128/JVI.79.10.6023-6034.2005 N1 - 10.1128/JVI.79.10.6023-6034.2005 UR - http://dx.doi.org/10.1128/JVI.79.10.6023-6034.2005 ER - TY - JOUR AU - Foy, E. TI - Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling JO - Proc. Natl Acad. Sci. USA PY - 2005/// VL - 102 SP - 2986 EP - 2991 M3 - 10.1073/pnas.0408707102 N1 - 10.1073/pnas.0408707102 UR - http://dx.doi.org/10.1073/pnas.0408707102 ER - TY - JOUR AU - Li, K. TI - Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF JO - Proc. Natl Acad. Sci. USA PY - 2005/// VL - 102 SP - 2992 EP - 2997 M3 - 10.1073/pnas.0408824102 N1 - 10.1073/pnas.0408824102 UR - http://dx.doi.org/10.1073/pnas.0408824102 ER - TY - JOUR AU - Crotta, S. TI - Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein JO - J. Exp. Med. PY - 2002/// VL - 195 SP - 35 EP - 41 M3 - 10.1084/jem.20011124 N1 - 10.1084/jem.20011124 UR - http://dx.doi.org/10.1084/jem.20011124 ER - TY - JOUR AU - Tseng, C. T. AU - Klimpel, G. R. TI - Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions JO - J. Exp. Med. PY - 2002/// VL - 195 SP - 43 EP - 49 M3 - 10.1084/jem.20011145 N1 - 10.1084/jem.20011145 UR - http://dx.doi.org/10.1084/jem.20011145 ER - TY - JOUR AU - Erickson, A. L. TI - The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes JO - Immunity PY - 2001/// VL - 15 SP - 883 EP - 895 M3 - 10.1016/S1074-7613(01)00245-X N1 - 10.1016/S1074-7613(01)00245-X UR - http://dx.doi.org/10.1016/S1074-7613(01)00245-X ER - TY - JOUR AU - Weiner, A. J. TI - Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections JO - Proc. Natl Acad. Sci. USA PY - 1992/// VL - 89 SP - 3468 EP - 3472 ER - TY - JOUR AU - Kato, N. TI - Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus JO - J. Virol. PY - 1993/// VL - 67 SP - 3923 EP - 3930 ER - TY - JOUR AU - Farci, P. TI - The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies JO - Science PY - 2000/// VL - 288 SP - 339 EP - 344 M3 - 10.1126/science.288.5464.339 N1 - 10.1126/science.288.5464.339 UR - http://dx.doi.org/10.1126/science.288.5464.339 ER - TY - JOUR AU - Farci, P. TI - Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein JO - Proc. Natl Acad. Sci. USA PY - 1996/// VL - 93 SP - 15394 EP - 15399 M3 - 10.1073/pnas.93.26.15394 N1 - 10.1073/pnas.93.26.15394 UR - http://dx.doi.org/10.1073/pnas.93.26.15394 ER - TY - JOUR AU - Thomssen, R. AU - Bonk, S. AU - Propfe, C. AU - Heermann, K. H. AU - Kochel, H. G. AU - Uy, A. TI - Association of hepatitis C virus in human sera with beta-lipoprotein JO - Med. Microbiol. Immunol. PY - 1992/// VL - 181 SP - 293 EP - 300 M3 - 10.1007/BF00198849 N1 - 10.1007/BF00198849 UR - http://dx.doi.org/10.1007/BF00198849 ER - TY - JOUR AU - Wedemeyer, H. TI - Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection JO - J. Immunol. PY - 2002/// VL - 169 SP - 3447 EP - 3458 ER - TY - JOUR AU - Semmo, N. TI - Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection JO - Hepatology PY - 2005/// VL - 41 SP - 1019 EP - 1028 M3 - 10.1002/hep.20669 N1 - 10.1002/hep.20669 UR - http://dx.doi.org/10.1002/hep.20669 ER - TY - JOUR AU - Khakoo, S. I. TI - HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection JO - Science PY - 2004/// VL - 305 SP - 872 EP - 874 M3 - 10.1126/science.1097670 N1 - 10.1126/science.1097670 UR - http://dx.doi.org/10.1126/science.1097670 ER - TY - JOUR AU - Ralston, R. TI - Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses JO - J. Virol. PY - 1993/// VL - 67 SP - 6753 EP - 6761 ER - TY - JOUR AU - Choo, Q. L. TI - Vaccination of chimpanzees against infection by the hepatitis C virus JO - Proc. Natl Acad. Sci. USA PY - 1994/// VL - 91 SP - 1294 EP - 1298 ER - TY - JOUR AU - Rosa, D. TI - A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells JO - Proc. Natl Acad. Sci. USA PY - 1996/// VL - 93 SP - 1759 EP - 1763 M3 - 10.1073/pnas.93.5.1759 N1 - 10.1073/pnas.93.5.1759 UR - http://dx.doi.org/10.1073/pnas.93.5.1759 ER - TY - JOUR AU - Pileri, P. TI - Binding of hepatitis C virus to CD81 JO - Science PY - 1998/// VL - 282 SP - 938 EP - 941 M3 - 10.1126/science.282.5390.938 N1 - 10.1126/science.282.5390.938 UR - http://dx.doi.org/10.1126/science.282.5390.938 ER - TY - JOUR AU - McKeating, J. A. TI - Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner JO - J. Virol. PY - 2004/// VL - 78 SP - 8496 EP - 8505 M3 - 10.1128/JVI.78.16.8496-8505.2004 N1 - 10.1128/JVI.78.16.8496-8505.2004 UR - http://dx.doi.org/10.1128/JVI.78.16.8496-8505.2004 ER - TY - GEN AU - Houghton, M. TI - Viral Hepatitis and Liver Disease PY - 1997/// ER - TY - GEN AU - Coates, S. TI - Proceedings of the 11th International Symposium on Viral Hepatitis and Liver Disease PY - 2005/// ER - TY - JOUR AU - Prince, A. M. TI - Reliability of chimpanzee model for non-A, non-B hepatitis JO - Lancet PY - 1985/// VL - ii SP - 1134 EP - 1134 M3 - 10.1016/S0140-6736(85)90730-5 N1 - 10.1016/S0140-6736(85)90730-5 UR - http://dx.doi.org/10.1016/S0140-6736(85)90730-5 ER - TY - JOUR AU - Rollier, C. TI - Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response JO - J. Virol. PY - 2004/// VL - 78 SP - 187 EP - 196 M3 - 10.1128/JVI.78.1.187-196.2004 N1 - 10.1128/JVI.78.1.187-196.2004 UR - http://dx.doi.org/10.1128/JVI.78.1.187-196.2004 ER - TY - JOUR AU - Puig, M. AU - Major, M. E. AU - Mihalik, K. AU - Feinstone, S. M. TI - Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection JO - Vaccine PY - 2004/// VL - 22 SP - 991 EP - 1000 M3 - 10.1016/j.vaccine.2003.09.010 N1 - 10.1016/j.vaccine.2003.09.010 UR - http://dx.doi.org/10.1016/j.vaccine.2003.09.010 ER - TY - JOUR AU - Forns, X. TI - Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV JO - Hepatology PY - 2000/// VL - 32 SP - 618 EP - 625 M3 - 10.1053/jhep.2000.9877 N1 - 10.1053/jhep.2000.9877 UR - http://dx.doi.org/10.1053/jhep.2000.9877 ER - TY - JOUR AU - Catalucci, D. AU - Sporeno, E. AU - Cirillo, A. AU - Ciliberto, G. AU - Nicosia, A. AU - Colloca, S. TI - An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors JO - J. Virol. PY - 2005/// VL - 79 SP - 6400 EP - 6409 M3 - 10.1128/JVI.79.10.6400-6409.2005 N1 - 10.1128/JVI.79.10.6400-6409.2005 UR - http://dx.doi.org/10.1128/JVI.79.10.6400-6409.2005 ER - TY - JOUR AU - Pancholi, P. AU - Perkus, M. AU - Tricoche, N. AU - Liu, Q. AU - Prince, A. M. TI - DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice JO - J. Virol. PY - 2003/// VL - 77 SP - 382 EP - 390 M3 - 10.1128/JVI.77.1.382-390.2003 N1 - 10.1128/JVI.77.1.382-390.2003 UR - http://dx.doi.org/10.1128/JVI.77.1.382-390.2003 ER - TY - JOUR AU - Brinster, C. TI - Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles JO - J. Gen. Virol. PY - 2002/// VL - 83 SP - 369 EP - 381 ER - TY - JOUR AU - Perri, S. TI - An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector JO - J. Virol. PY - 2003/// VL - 77 SP - 10394 EP - 10403 M3 - 10.1128/JVI.77.19.10394-10403.2003 N1 - 10.1128/JVI.77.19.10394-10403.2003 UR - http://dx.doi.org/10.1128/JVI.77.19.10394-10403.2003 ER - TY - JOUR AU - Abraham, J. D. TI - Comparative immunogenicity analysis of modified vaccinia Ankara vectors expressing native or modified forms of hepatitis C virus E1 and E2 glycoproteins JO - Vaccine PY - 2004/// VL - 22 SP - 3917 EP - 3928 M3 - 10.1016/j.vaccine.2004.04.005 N1 - 10.1016/j.vaccine.2004.04.005 UR - http://dx.doi.org/10.1016/j.vaccine.2004.04.005 ER - TY - JOUR AU - Wuest, T. AU - Both, G. W. AU - Prince, A. M. AU - Hofmann, C. AU - Loser, P. TI - Recombinant ovine atadenovirus induces a strong and sustained T cell response against the hepatitis C virus NS3 antigen in mice JO - Vaccine PY - 2004/// VL - 22 SP - 2717 EP - 2721 M3 - 10.1016/j.vaccine.2004.01.048 N1 - 10.1016/j.vaccine.2004.01.048 UR - http://dx.doi.org/10.1016/j.vaccine.2004.01.048 ER - TY - JOUR AU - O'Hagan, D. T. TI - Cationic microparticles are a potent delivery system for a HCV DNA vaccine JO - Vaccine PY - 2004/// VL - 23 SP - 672 EP - 680 M3 - 10.1016/j.vaccine.2004.06.037 N1 - 10.1016/j.vaccine.2004.06.037 UR - http://dx.doi.org/10.1016/j.vaccine.2004.06.037 ER - TY - JOUR AU - Jeong, S. H. TI - Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates JO - J. Virol. PY - 2004/// VL - 78 SP - 6995 EP - 7003 M3 - 10.1128/JVI.78.13.6995-7003.2004 N1 - 10.1128/JVI.78.13.6995-7003.2004 UR - http://dx.doi.org/10.1128/JVI.78.13.6995-7003.2004 ER - TY - JOUR AU - Krahn, M. D. TI - Potential cost-effectiveness of a preventive hepatitis C vaccine in high risk and average risk populations in Canada JO - Vaccine PY - 2005/// VL - 23 SP - 1549 EP - 1558 M3 - 10.1016/j.vaccine.2004.09.023 N1 - 10.1016/j.vaccine.2004.09.023 UR - http://dx.doi.org/10.1016/j.vaccine.2004.09.023 ER - TY - JOUR AU - Saadeh, S. AU - Davis, G. L. TI - The evolving treatment of chronic hepatitis C: where we stand a decade out JO - Cleveland Clin. J. Med. PY - 2004/// VL - 71 SP - S3 EP - S7 ER - TY - JOUR AU - Baumert, T. F. TI - Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C JO - Hepatology PY - 2000/// VL - 32 SP - 610 EP - 617 M3 - 10.1053/jhep.2000.9876 N1 - 10.1053/jhep.2000.9876 UR - http://dx.doi.org/10.1053/jhep.2000.9876 ER - TY - JOUR AU - Cramp, M. E. AU - Rossol, S. AU - Chokshi, S. AU - Carucci, P. AU - Williams, R. AU - Naoumov, N. V. TI - Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C JO - Gastroenterology PY - 2000/// VL - 118 SP - 346 EP - 355 ER - TY - JOUR AU - Nelson, D. R. AU - Marousis, C. G. AU - Ohno, T. AU - Davis, G. L. AU - Lau, J. Y. TI - Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C JO - Hepatology PY - 1998/// VL - 28 SP - 225 EP - 230 M3 - 10.1002/hep.510280129 N1 - 10.1002/hep.510280129 UR - http://dx.doi.org/10.1002/hep.510280129 ER - TY - JOUR AU - Vrolijk, J. M. TI - Pretreatment intrahepatic CD8+ cell count correlates with virological response to antiviral therapy in chronic hepatitis C virus infection JO - J. Infect. Dis. PY - 2003/// VL - 188 SP - 1528 EP - 1532 M3 - 10.1086/379334 N1 - 10.1086/379334 UR - http://dx.doi.org/10.1086/379334 ER - TY - JOUR AU - Nevens, F. TI - A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C JO - Hepatology PY - 2003/// VL - 38 SP - 1289 EP - 1296 M3 - 10.1053/jhep.2003.50474 N1 - 10.1053/jhep.2003.50474 UR - http://dx.doi.org/10.1053/jhep.2003.50474 ER - TY - JOUR AU - Abel, K. TI - Deoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in Rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing Rhesus monkey plasmacytoid den JO - Clin. Diagn. Lab. Immunol. PY - 2005/// VL - 12 SP - 606 EP - 621 M3 - 10.1128/CDLI.12.5.606-621.2005 N1 - 10.1128/CDLI.12.5.606-621.2005 UR - http://dx.doi.org/10.1128/CDLI.12.5.606-621.2005 ER - TY - JOUR AU - Oxman, M. N. TI - A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults JO - N. Engl. J. Med. PY - 2005/// VL - 352 SP - 2271 EP - 2284 M3 - 10.1056/NEJMoa051016 N1 - 10.1056/NEJMoa051016 UR - http://dx.doi.org/10.1056/NEJMoa051016 ER - TY - JOUR AU - Leroux-Roels, G. TI - A candidate vaccine based on the hepatitis C E1 protein: tolerability and immunogenicity in healthy volunteers JO - Vaccine PY - 2004/// VL - 22 SP - 3080 EP - 3086 M3 - 10.1016/j.vaccine.2004.02.002 N1 - 10.1016/j.vaccine.2004.02.002 UR - http://dx.doi.org/10.1016/j.vaccine.2004.02.002 ER - TY - JOUR AU - Franzusoff, A. AU - Duke, R. C. AU - King, T. H. AU - Lu, Y. AU - Rodell, T. C. TI - Yeasts encoding tumour antigens in cancer immunotherapy JO - Exp. Opin. Biol. Ther. PY - 2005/// VL - 5 SP - 565 EP - 575 M3 - 10.1517/14712598.5.4.565 N1 - 10.1517/14712598.5.4.565 UR - http://dx.doi.org/10.1517/14712598.5.4.565 ER -